Established in 1986, Ind-Swift is a research driven pharmaceutical group known for world class finished dosage forms, active pharmaceutical ingredients, and intermediates. Products Ind Swift Limited are available in many countries of EU, Australia, Canada, Central & Latin America, Asia, CIS and Africa-including South Africa. Ind-Swift is approved by MHRA, TGA, Health Canada, MCC, MOH-UAE, FDA-Taiwan, PHP-Philippines, TFDA-Tanzania, FMHACA-Ethiopia, PPB-Kenya, NDA-Uganda, MCAZ-Zimbabwe, Ukraine-GMP, WHO-GMP for tablets, hard gelatin capsules and dry powder-sachet. Our focus for the prospective years is on both the developed markets ( European Union, Australia, Canada, Brazil, South Africa) & semi regulated markets (Africa, South East Asia, Latin America, & the CIS countries). Ind Swift Limited today has become a leading player as a contract Manufacturer due to its efficient and lean supply management delivering quality products on time as per customer demand.